0 items USD 0.00Search
Your search for "mrrpb5 global glycosylated biosimilars market research report 2019" gave back 94764 results.
Biosimilar is the identical copy of oncology biologics used for the treatment of cancer and officially approved for the treatment of cancer. These...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
The global Rituximab Biosimilars market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
Biosimilar are the biological based products used for various use in healthcare industry. Biosimilar products are very helpful to the patients and...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Biosimilar insulin is likely to enter the insulin landscape as patents for major branded insulin products start to expire in the next few years...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
Pegfilgrastim is developed by PEGylating the recombinant human granulocyte colony-stimulating factor (G-CSF) analogue, filgrastim. Pegfilgrastim was...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
Ranibizumab, sold under the brand name Lucentis among others, is a monoclonal antibody fragment (Fab) created from the same parent mouse antibody as...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Brolucizumab is a humanized single-chain antibody fragment for the treatment of neovascular (wet) age-related macular degeneration (AMD). The most...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Omalizumab is a medication used to treat asthma, nasal polyps, and urticaria. Omalizumab is a recombinant DNA-derived humanized IgG1k monoclonal...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Market Analysis and Insights: Global Generic and Biosimilar Pharmaceuticals Market The global Generic and Biosimilar Pharmaceuticals market is...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Omalizumab monoclonal antibody biosimilar is a medication used to treat asthma, nasal polyps, and urticaria. Omalizumab is a recombinant DNA-derived...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Biosimilar is a biologic medical product which is highly similar to another already approved biological medicine. The global Adalimumab, Infliximab...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
MUC1 ELISA kits are immunoassay tools for the measurement of the protein mucin 1, cell surface associated, which is encoded by the MUC1 gene in...
Catalog:
MRRPB5
March 2024
Price: USD 2,900.00
Ranibizumab, sold under the brand name Lucentis among others, is a monoclonal antibody fragment (Fab) created from the same parent mouse antibody as...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Aflibercept is a medication used to treat wet macular degeneration and metastatic colorectal cancer. It is an inhibitor of vascular endothelial...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Avastin (Bevacizumab) is a medication used to treat a number of types of cancers and a specific eye disease. For cancer, it is given by slow...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
